Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform.
about
Targeting LKB1 in cancer - exposing and exploiting vulnerabilitiesNovel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts.Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
P2860
Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bridging tumor genomics to pat ...... nt-derived xenograft platform.
@ast
Bridging tumor genomics to pat ...... nt-derived xenograft platform.
@en
type
label
Bridging tumor genomics to pat ...... nt-derived xenograft platform.
@ast
Bridging tumor genomics to pat ...... nt-derived xenograft platform.
@en
prefLabel
Bridging tumor genomics to pat ...... nt-derived xenograft platform.
@ast
Bridging tumor genomics to pat ...... nt-derived xenograft platform.
@en
P2093
P2860
P1433
P1476
Bridging tumor genomics to pat ...... nt-derived xenograft platform.
@en
P2093
Carol Bult
Chong-Xian Pan
David T Cooke
Edison T Liu
Elizabeth A David
Elizabeth H Moore
James G Keck
Jonathan W Riess
Ken Y Yoneda
Neal Goodwin
P2860
P304
P356
10.1016/J.CLLC.2015.03.001
P407
P577
2015-03-18T00:00:00Z